Heyn J, Azad S C
Klinik für Anaesthesiologie, Interdisziplinäre Schmerzambulanz und Tagesklinik, Ludwig-Maximilians Universität München (LMU), Marchioninistraße 15, 81377, München, Deutschland.
Anaesthesist. 2017 Nov;66(11):829-839. doi: 10.1007/s00101-017-0369-2.
Due to their strong analgesic potency opioids are highly effective in the therapy of acute and particularly cancer-induced chronic pain; however, the individual opioids differ considerably with respect to their pharmacokinetic and physicochemical properties and may therefore not be equally applicable for every patient. Caution should be taken especially in patients with impaired organ function. Furthermore, the metabolism of opioids leads to active or inactive metabolites. This process can be substantially influenced by genetic polymorphisms or drug interactions. Knowledge of all these factors for individual opioids, which influence the efficacy and side effects, is therefore crucial. In this review the pharmacology, clinical applications, metabolism and genetic factors of the most important opioids used for pain management are discussed.
由于其强大的镇痛效力,阿片类药物在急性疼痛尤其是癌症引起的慢性疼痛治疗中非常有效;然而,不同的阿片类药物在药代动力学和物理化学性质方面存在很大差异,因此可能并非对每个患者都同样适用。特别是对于器官功能受损的患者应格外谨慎。此外,阿片类药物的代谢会产生活性或非活性代谢物。这个过程会受到基因多态性或药物相互作用的显著影响。因此,了解影响阿片类药物疗效和副作用的所有这些个体因素至关重要。在这篇综述中,讨论了用于疼痛管理的最重要阿片类药物的药理学、临床应用、代谢和遗传因素。